[Treatment of spasticity with botulinum toxin: implications for molecular targeting therapy for CNS diseases].
Kaji
Ryuji
R
D001905:Botulinum Toxins / Q000008:administration & dosage*; D001927:Brain Diseases / Q000150:complications; D016503:Drug Delivery Systems; D006801:Humans; D009128:Muscle Spasticity / Q000188:drug therapy*
D001905:Botulinum Toxins